Skip to main content
Journal cover image

When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective.

Publication ,  Journal Article
Parisi, MA; Caggana, M; Cohen, JL; Gold, NB; Morris, JA; Orsini, JJ; Urv, TK; Wasserstein, MP
Published in: Am J Med Genet C Semin Med Genet
March 2023

This paper focuses on the question of, "When is the best time to identify an individual at risk for a treatable genetic condition?" In this review, we describe a framework for considering the optimal timing for pursuing genetic and genomic screening for treatable genetic conditions incorporating a lifespan approach. Utilizing the concept of a carousel that represents the four broad time periods when critical decisions might be made around genetic diagnoses during a person's lifetime, we describe genetic testing during the prenatal period, the newborn period, childhood, and adulthood. For each of these periods, we describe the objectives of genetic testing, the current status of screening or testing, the near-term vision for the future of genomic testing, the advantages and disadvantages of each approach, and the feasibility and ethical considerations of testing and treating. The notion of a "Genomics Passbook" is one where an early genomic screening evaluation could be performed on each individual through a public health program, with that data ultimately serving as a "living document" that could be queried and/or reanalyzed at prescribed times during the lifetime of that person, or in response to concerns about symptoms of a genetic disorder in that individual.

Duke Scholars

Published In

Am J Med Genet C Semin Med Genet

DOI

EISSN

1552-4876

Publication Date

March 2023

Volume

193

Issue

1

Start / End Page

44 / 55

Location

United States

Related Subject Headings

  • Longevity
  • Infant, Newborn
  • Humans
  • Genetics & Heredity
  • Genetic Testing
  • Child
  • 3202 Clinical sciences
  • 3105 Genetics
  • 1103 Clinical Sciences
  • 0604 Genetics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Parisi, M. A., Caggana, M., Cohen, J. L., Gold, N. B., Morris, J. A., Orsini, J. J., … Wasserstein, M. P. (2023). When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective. Am J Med Genet C Semin Med Genet, 193(1), 44–55. https://doi.org/10.1002/ajmg.c.32036
Parisi, Melissa A., Michele Caggana, Jennifer L. Cohen, Nina B. Gold, Jill A. Morris, Joseph J. Orsini, Tiina K. Urv, and Melissa P. Wasserstein. “When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective.Am J Med Genet C Semin Med Genet 193, no. 1 (March 2023): 44–55. https://doi.org/10.1002/ajmg.c.32036.
Parisi MA, Caggana M, Cohen JL, Gold NB, Morris JA, Orsini JJ, et al. When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective. Am J Med Genet C Semin Med Genet. 2023 Mar;193(1):44–55.
Parisi, Melissa A., et al. “When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective.Am J Med Genet C Semin Med Genet, vol. 193, no. 1, Mar. 2023, pp. 44–55. Pubmed, doi:10.1002/ajmg.c.32036.
Parisi MA, Caggana M, Cohen JL, Gold NB, Morris JA, Orsini JJ, Urv TK, Wasserstein MP. When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective. Am J Med Genet C Semin Med Genet. 2023 Mar;193(1):44–55.
Journal cover image

Published In

Am J Med Genet C Semin Med Genet

DOI

EISSN

1552-4876

Publication Date

March 2023

Volume

193

Issue

1

Start / End Page

44 / 55

Location

United States

Related Subject Headings

  • Longevity
  • Infant, Newborn
  • Humans
  • Genetics & Heredity
  • Genetic Testing
  • Child
  • 3202 Clinical sciences
  • 3105 Genetics
  • 1103 Clinical Sciences
  • 0604 Genetics